Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (21 quarters reported)
$21.1M in Q2 2021 → $1.25M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Tscan Therapeutics Inc | 49.3% | Unchanged | 630,000 | $617K |
| BB Barinthus Biotherapeutics Pl | 33.8% | Unchanged | 642,204 | $424K |
| Werewolf Therapeutics Inc | 16.9% | Unchanged | 589,102 | $212K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 14, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed February 13, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed November 10, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 14, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 14, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 14, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed November 14, 2024
No position changes this quarter.
Loading...
